Similar articles

• [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].

  Dahlström U, Alehagen U. Dahlström U, et al. Lakartidningen. 2006 Mar 22-28;103(12):927-9. Lakartidningen. 2006. PMID: 16618036 Review. Swedish. No abstract available.
• [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].

  Lindstedt G, Dahlström U, Fernlund P, Schaufelberger M, Stridsberg M. Lindstedt G, et al. Lakartidningen. 2001 Oct 10;98(41):4444-8, 4450-2. Lakartidningen. 2001. PMID: 11699251 Review. Swedish.
• [Diagnosis of heart failure with the help of natriuretic peptides. Practical tool in primary health care].

  Theodorsson E. Theodorsson E. Lakartidningen. 2001 Oct 10;98(41):4427. Lakartidningen. 2001. PMID: 11699247 Swedish. No abstract available.
• National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.

  Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH; NACB Committee; IFCC C-SMCD. Apple FS, et al. Clin Biochem. 2008 Mar;41(4-5):222-6. doi: 10.1016/j.clinbiochem.2007.07.001. Epub 2007 Nov 26. Clin Biochem. 2008. PMID: 18035345 No abstract available.
• [Monitoring heart failure with brain natriuretic peptide].

  Sela B. Sela B. Harefuah. 2003 Jan;142(1):25-31, 78. Harefuah. 2003. PMID: 12647486 Hebrew.